GB202017118D0 - Coronavirus polypeptide - Google Patents

Coronavirus polypeptide

Info

Publication number
GB202017118D0
GB202017118D0 GBGB2017118.7A GB202017118A GB202017118D0 GB 202017118 D0 GB202017118 D0 GB 202017118D0 GB 202017118 A GB202017118 A GB 202017118A GB 202017118 D0 GB202017118 D0 GB 202017118D0
Authority
GB
United Kingdom
Prior art keywords
coronavirus polypeptide
coronavirus
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2017118.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Vacmedix Uk Ltd
Original Assignee
Oxford Vacmedix Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Vacmedix Uk Ltd filed Critical Oxford Vacmedix Uk Ltd
Priority to GBGB2017118.7A priority Critical patent/GB202017118D0/en
Publication of GB202017118D0 publication Critical patent/GB202017118D0/en
Priority to PCT/GB2021/051129 priority patent/WO2022090679A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB2017118.7A 2020-10-28 2020-10-28 Coronavirus polypeptide Ceased GB202017118D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2017118.7A GB202017118D0 (en) 2020-10-28 2020-10-28 Coronavirus polypeptide
PCT/GB2021/051129 WO2022090679A1 (en) 2020-10-28 2021-05-11 Coronavirus polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2017118.7A GB202017118D0 (en) 2020-10-28 2020-10-28 Coronavirus polypeptide

Publications (1)

Publication Number Publication Date
GB202017118D0 true GB202017118D0 (en) 2020-12-09

Family

ID=73727114

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2017118.7A Ceased GB202017118D0 (en) 2020-10-28 2020-10-28 Coronavirus polypeptide

Country Status (2)

Country Link
GB (1) GB202017118D0 (en)
WO (1) WO2022090679A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116925177A (en) * 2021-12-06 2023-10-24 浙江大学 Novel affinity polypeptide of coronavirus spike protein receptor binding region RBD and application thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202209115D0 (en) 2022-06-21 2022-08-10 Chain Biotechnology Ltd Compositions and methods
WO2024044747A2 (en) * 2022-08-25 2024-02-29 University Of Florida Research Foundation, Inc. Immunogenic composition and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608368D0 (en) 2006-04-28 2006-06-07 Isis Innovation Process for making Oligopeptides
CN105753989A (en) 2014-12-15 2016-07-13 牛津疫苗医学生物科技（英国）有限公司 Artificial multi-antigen fusion protein, and preparation method and application thereof
CN111533809A (en) * 2020-04-21 2020-08-14 中国科学院武汉病毒研究所 Subunit vaccine for novel coronavirus and application
CN111732637B (en) 2020-05-25 2022-03-01 上海交通大学 Polypeptide for inhibiting novel coronavirus SARS-CoV-2 from infecting host cell and its application
CN111560054A (en) 2020-06-16 2020-08-21 哈尔滨吉象隆生物技术有限公司 Polypeptide for inhibiting novel coronavirus infection and screening method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116925177A (en) * 2021-12-06 2023-10-24 浙江大学 Novel affinity polypeptide of coronavirus spike protein receptor binding region RBD and application thereof

Also Published As

Publication number Publication date
WO2022090679A1 (en) 2022-05-05

Similar Documents

Publication Publication Date Title
CA216403S (en) Hoodie
GB202007045D0 (en) Coronavirus
GB202017118D0 (en) Coronavirus polypeptide
GB202017649D0 (en) Polypeptide
GB202007441D0 (en) Polypeptide
GB202007532D0 (en) Polypeptides
IL308465A (en) Sars-cov-2 polypeptides
IL299811A (en) Polypeptide
GB202019879D0 (en) Polypeptide
GB202004755D0 (en) Coronavirus
GB202003980D0 (en) Coronavirus Antibody
IL311448A (en) Polypeptide
GB202119034D0 (en) Polypeptide
GB202105924D0 (en) Polypeptide
GB202103001D0 (en) Polypeptide
GB202100648D0 (en) Polypeptide
GB202013372D0 (en) Polypeptide
GB202011813D0 (en) Polypeptide
GB202005333D0 (en) Polypeptide
GB202008636D0 (en) Coronavirus west
CA217436S (en) Footwarmer
CA214906S (en) Multi-cooker
CA215434S (en) Thermo-hygrometer
CA200433S (en) Can
CA210085S (en) Muddler

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)